Chang KC, Lin MT, Wang JH, Hung CH, Chen CH, Chiu SY*, Hu TH*. HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. Viruses. 2022 Nov 29;14(12):2671. (SCI)
Hu TH, Yueh-Hsia Chiu S, Tseng PL, Chen CH, Lu SN, Wang JH, Hung CH, Kee KM, Lin MT, Chang KC*, Lin MC, Chien RN*. Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naive patients with chronic hepatitis B-related compensated cirrhosis in Taiwan. Aliment Pharmacol Ther. 2020 Dec;52(11-12):1695-1706. (SCI)
Chang KC*, Ye YH, Wu CK, Lin MT, Tsai MC, Tseng PL, Hu TH. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy. J Formos Med Assoc. 2018 Nov;117(11):1011-1018. (SCI)
Chang KC, Tseng PL, Wu YY, Hung CH, Huang CM, Lu SN, Wang JH, Lee CM, Chen CH, Tsai MC, Yen YH, Lin MT, Wu CK, Huang CC, Chen HH, Hu TH*. A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection. Clin Gastroenterol Hepatol. 2015 May;13(5):1017-24. (SCI)
Chang KC, Wu YY, Hung CH, Lu SN, Lee CM, Chiu KW, Tsai MC, Tseng PL, Huang CM, Cho CL, Chen HH, Hu TH*. Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy. Br J Cancer. 2013 Oct 29;109(9):2481-8. (SCI)
Lin SC, Chuah SK, Wu KL, Chiu KW, Chang KC*, Chiu YC, Chou YP, Hu ML, Tai WC, Chiou SS, Hu TH, Changchien CS. Endoscopic management of adult foreign bodies in the upper-GI tract：clinical experiences at a tertiary hospital in Southern Taiwan. Gastroenterol J Taiwan 2012 Dec; 29(4): 326-333.
Chang KC, Hung CH, Lu SN, Wang JH, Lee CM, Chen CH, Yen MF, Lin SC, Yen YH, Tsai MC, Tseng PL, Hu TH*. A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy. J Antimicrob Chemother. 2012 Nov;67(11):2766-72. (SCI)
Chang KC, Lu SN, Chen PF, Hung CH, Kee KM, Yen YH, Wang JH*. Incidence and associated risk factors of hepatocellular carcinoma in a dural hepatitis B and C virus endemic area: a surveillance study. Kaohsiung J Med Sci. 2011 Mar;27(3):85-90. (SCI)
Chang KC, Tsai PS, Hsu MC, Hung SF, Tsai CC, Lu SN*. Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community. J Gastroenterol. 2010 Jun;45(6):636-45. (SCI)
Chang KC, Tai MH, Lin JW, Wang CC, Huang CC, Hung CH, Chen CH, Lu SN, Lee CM, Changchien CS, Hu TH*. Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors. Int J Cancer. 2007 Sep 1;121(5):1059-65. (SCI)
Chang KC, Chuah SK, Changchien CS, Tsai TL, Lu SN, Chiu YC, Chen YS, Wang CC, Lin JW, Lee CM, Hu TH*. Clinical characteristics and prognostic factors of splenic abscess: a review of 67 cases in a single medical center of Taiwan. World J Gastroenterol. 2006 Jan 21;12(3):460-4. (SCI)
Chang KC, Changchien CS, Kuo CM, Chiu YC, Chuah SK, Chiu KW, Kuo CH*. Clinical analysis of the efficacy in Lipase/Amylase ratio for acute pancreatitis. J Int Med Taiwan. 2005; 16(3): 113-120.
